Zepbound also operates by mimicking a hormone that regulates appetite, helping control feelings of hunger and satiety
The SURMOUNT-5 trial published in the New England Journal of Medicine in May 2025 was the first randomized, head-to-head comparison of the two medications in patients with obesity but without type 2 diabetes
However, after a sharp decrease in weight, signs of ptosis show up on the face: The fat layer becomes thinner
Despite this signal, the absolute number of events remained low because NAION is rare
If you're unsure where to start, me and my team can guide you toward the best solution for your body
Comparative analysis revealed that oral administration is more likely to induce gastrointestinal disorders such as pancreatitis, pancreatic cancer, belching, gastric emptying disorders, and gallstones when compared to subcutaneous injection